0001213900-22-042964.txt : 20220729 0001213900-22-042964.hdr.sgml : 20220729 20220729162027 ACCESSION NUMBER: 0001213900-22-042964 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20220728 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220729 DATE AS OF CHANGE: 20220729 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Compute Health Acquisition Corp. CENTRAL INDEX KEY: 0001828608 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40001 FILM NUMBER: 221121067 BUSINESS ADDRESS: STREET 1: 1105 NORTH MARKET STREET, SUITE 1300 CITY: WILMINGTON STATE: DE ZIP: 19801 BUSINESS PHONE: (212) 829-3500 MAIL ADDRESS: STREET 1: 1105 NORTH MARKET STREET, SUITE 1300 CITY: WILMINGTON STATE: DE ZIP: 19801 8-K 1 ea163491-8k_compute.htm CURRENT REPORT
0001828608 false 0001828608 2022-07-28 2022-07-28 0001828608 CPUH:UnitsEachConsistingOfOneShareOfClassaCommonStockAndOnequarterOfOneRedeemableWarrantMember 2022-07-28 2022-07-28 0001828608 CPUH:ClassaCommonStockParValue0.0001PerShareMember 2022-07-28 2022-07-28 0001828608 CPUH:RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassaCommonStockAtExercisePriceOf11.50Member 2022-07-28 2022-07-28 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): July 29, 2022 (July 28, 2022)

 

COMPUTE HEALTH ACQUISITION CORP.

(Exact name of registrant as specified in its charter)

 

Delaware   001-40001   85-3449307
(State or other jurisdiction
of incorporation)
  (Commission
File Number)
  (IRS Employer
Identification No.)

 

1105 North Market Street

4th Floor

Wilmington, DE 19890

(Address of principal executive offices) (Zip Code)

  

(212) 829-3500

(Registrant’s telephone number, including area code)

 

Not Applicable
(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
         
Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant   CPUH.U   The New York Stock Exchange
         
Class A common stock, par value $0.0001 per share   CPUH   The New York Stock Exchange
         
Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50   CPUH WS   The New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

 

 

 

 

Item 1.01 Entry into a Material Definitive Agreement.

 

On July 28, 2022, Compute Health Acquisition Corp. (“Compute Health”) entered into a Loan Note Instrument (the “Loan Note”) with Compute Health Sponsor LLC (“Payee”), pursuant to which, Payee, in its sole and absolute discretion, may loan to Compute Health up to $1,500,000 for costs reasonably related to Compute Health’s consummation of an initial business combination. The Loan Note does not bear any interest.

 

The Loan Note is payable on the earliest to occur of (i) the date on which Compute Health consummates its initial business combination and (ii) the date that the winding up of Compute Health is effective.

 

The Loan Note is subject to customary events if default, including failure by Compute Health to pay the principal amount due pursuant to the Loan Note within five business days of the Maturity Date and certain bankruptcy events of Compute Health.  

 

A copy of the Loan Note is filed as Exhibit 10.1 to this Current Report on Form 8-K, and the foregoing description thereof is qualified in its entirety by reference to the full text of the Loan Note.

 

Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

 

The disclosure set forth above in Item 1.01 of this Current Report on Form 8-K are incorporated by reference into this Item 2.03.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.   Description
10.1   Loan Note

 

 

1

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  COMPUTE HEALTH ACQUISITION CORP.
     
  By: /s/ Joshua Fink
    Name: Joshua Fink
    Title: Co-Chief Executive Officer
     
Dated: July 29, 2022    

 

 

2

 

 

 

EX-10.1 2 ea163491ex10-1_computehealth.htm LOAN NOTE

Exhibit 10.1

 

THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”).  THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.  

 

PROMISSORY NOTE

 

Principal Amount:  Up to $1,500,000

 Dated as of July 28, 2022

 

 

Compute Health Acquisition Corp., a Delaware corporation (“Maker”), promises to pay to the order of Compute Health Sponsor LLC, a Delaware limited liability company or its registered assigns or successors in interest or order (“Payee”), the principal sum of up to One Million Five Hundred Thousand Dollars ($1,500,000.00) in lawful money of the United States of America, on the terms and conditions described below.  All payments on this Note (unless the full principal is converted pursuant to Section 15 below) shall be made by check or wire transfer of immediately available funds to such account as Payee may from time to time designate by written notice in accordance with the provisions of this Note.

 

  1. Repayment. The principal balance of this Note shall be payable on the earliest to occur of (i) the date on which Maker consummates its initial business combination and (ii) the date that the winding up of Maker is effective (such date, the “Maturity Date”). The principal balance may be prepaid at any time, at the election of Maker.

 

  2. Interest. This Note shall be non-interest bearing.

 

  3. Drawdown Requests. Payee, in its sole and absolute discretion, may fund up to One Million Five Hundred Thousand Dollars ($1,500,000.00) for costs reasonably related to Maker’s consummation of an initial business combination. The principal of this Note may be drawn down from time to time until the date on which Maker consummates its initial business combination, upon written request from Maker to Payee (each, a “Drawdown Request”). Each Drawdown Request must state the amount to be drawn down, and must be in multiples of not less than Ten Thousand Dollars ($10,000) unless agreed upon by Maker and Payee. Payee, in its sole discretion, shall fund each Drawdown Request no later than five (5) business days after receipt of a Drawdown Request; provided, however, that the maximum amount of drawdowns collectively under this Note shall not exceed One Million Five Hundred Thousand Dollars ($1,500,000.00). Once an amount is drawn down under this Note, it shall not be available for future Drawdown Requests even if prepaid. Except as set forth herein, no fees, payments or other amounts shall be due to Payee in connection with, or as a result of, any Drawdown Request by Maker.

 

  4. Application of Payments. All payments received by Payee pursuant to this Note shall be applied first to the payment in full of any costs incurred in the collection of any sum due under this Note, including (without limitation) reasonable attorney’s fees, and then to the reduction of the unpaid principal balance of this Note.

 

 

 

  5. Events of Default. The following shall constitute an event of default (“Event of Default”):

 

(a) Failure to Make Required Payments. Failure by Maker to pay the principal amount due pursuant to this Note within five (5) business days of the Maturity Date.

 

(b) Voluntary Bankruptcy, etc. The commencement by Maker of a voluntary case under any applicable bankruptcy, insolvency, reorganization, rehabilitation or other similar law, or the consent by it to the appointment of or taking possession by a receiver, liquidator, assignee, trustee, custodian, sequestrator (or other similar official) of Maker or for any substantial part of its property, or the making by it of any assignment for the benefit of creditors, or the failure of Maker generally to pay its debts as such debts become due, or the taking of corporate action by Maker in furtherance of any of the foregoing.

 

(c) Involuntary Bankruptcy, Etc. The entry of a decree or order for relief by a court having jurisdiction in the premises in respect of Maker in an involuntary case under any applicable bankruptcy, insolvency or other similar law, or appointing a receiver, liquidator, assignee, custodian, trustee, sequestrator (or similar official) of Maker or for any substantial part of its property, or ordering the winding-up or liquidation of its affairs, and the continuance of any such decree or order unstayed and in effect for a period of 60 consecutive days.

 

6.       Remedies.

 

(a)           Upon the occurrence of an Event of Default specified in Section 5(a) hereof, Payee may, by written notice to Maker, declare this Note to be due immediately and payable, whereupon the unpaid principal amount of this Note and all other amounts payable hereunder, shall become immediately due and payable without presentment, demand, protest or other notice of any kind, all of which are hereby expressly waived, anything contained herein or in the documents evidencing the same to the contrary notwithstanding.

 

(b)           Upon the occurrence of an Event of Default specified in Sections 5(b) and 5(c) hereof, the unpaid principal balance of this Note and all other amounts payable hereunder, shall automatically and immediately become due and payable, in all cases without any action on the part of Payee.

 

7.       Waivers. Maker and all endorsers and guarantors of, and sureties for, this Note waive presentment for payment, demand, notice of dishonor, protest, and notice of protest with regard to this Note, all errors, defects and imperfections in any proceedings instituted by Payee under the terms of this Note, and all benefits that might accrue to Maker by virtue of any present or future laws exempting any property, real or personal, or any part of the proceeds arising from any sale of any such property, from attachment, levy or sale under execution, or providing for any stay of execution, exemption from civil process, or extension of time for payment; and Maker agrees that any real or personal property that may be levied upon pursuant to a judgment obtained by virtue hereof, on any writ of execution issued hereon, may be sold upon any such writ in whole or in part in any order desired by Payee.

 

8.       Unconditional Liability. Maker hereby waives all notices in connection with the delivery, acceptance, performance, default, or enforcement of the payment of this Note, and agrees that its liability shall be unconditional, without regard to the liability of any other party, and shall not be affected in any manner by any indulgence, extension of time, renewal, waiver or modification granted or consented to by Payee, and consents to any and all extensions of time, renewals, waivers, or modifications that may be granted by Payee with respect to the payment or other provisions of this Note, and agrees that additional makers, endorsers, guarantors, or sureties may become parties hereto without notice to Maker or affecting Maker’s liability hereunder.

 

9.       Notices. All notices, statements or other documents which are required or contemplated by this Note shall be: (i) in writing and delivered personally or sent by first class registered or certified mail, overnight courier service or facsimile or electronic transmission to the address designated in writing, (ii) by facsimile to the number most recently provided to such party or such other address or fax number as may be designated in writing by such party and (iii) by electronic mail, to the electronic mail address most recently provided to such party or such other electronic mail address as may be designated in writing by such party.  Any notice or other communication so transmitted shall be deemed to have been given on the day of delivery, if delivered personally, on the business day following receipt of written confirmation, if sent by facsimile or electronic transmission, one (1) business day after delivery to an overnight courier service or five (5) days after mailing if sent by mail.

 

10.    Construction. THIS NOTE SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE LAWS OF NEW YORK, WITHOUT REGARD TO THE CONFLICT OF LAWS PROVISIONS THEREOF.

 

11.    Severability. Any provision contained in this Note which is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.

 

 

 

12.    Trust Waiver.   Notwithstanding anything herein to the contrary, Payee hereby waives any claim in or to any distribution of or from the trust account (the “Trust Account”) established in connection with Maker’s initial public offering (the “IPO”) or any distributions to its public stockholders therefrom, and hereby agrees not to seek recourse, reimbursement, payment or satisfaction for any claim against the Trust Account or any distributions to its public stockholders therefrom for any reason whatsoever; provided, however, that upon the consummation of the initial business combination, Maker shall repay the principal balance of this Note first using the proceeds released to Maker from the Trust Account and not distributed to its public stockholders.

 

13.    Amendment; Waiver.  Any amendment hereto or waiver of any provision hereof may be made with, and only with, the written consent of Maker and Payee.

 

14.    Assignment.  No assignment or transfer of this Note or any rights or obligations hereunder may be made by any party hereto (by operation of law or otherwise) without the prior written consent of the other party hereto and any attempted assignment without the required consent shall be void; provided, however, that the foregoing shall not apply to an affiliate of Payee who agrees to be bound to the terms of this Note.

 

 

[Signature Page Follows]

 

 

        IN WITNESS WHEREOF, Maker, intending to be legally bound hereby, has caused this Note to be duly executed by the undersigned as of the day and year first above written.

 

  COMPUTE HEALTH ACQUISITION CORP.  
       
  By:   /s/ Joshua Fink  
    Name: Joshua Fink  
    Title: Co-Chief Executive Officer  

  

 

 

[Signature Page to Promissory Note]

 

EX-101.SCH 3 cpuh-20220728.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 4 cpuh-20220728_def.xml XBRL DEFINITION FILE EX-101.LAB 5 cpuh-20220728_lab.xml XBRL LABEL FILE Class of Stock [Axis] Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant Class A common stock, par value $0.0001 per share Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 6 cpuh-20220728_pre.xml XBRL PRESENTATION FILE XML 7 R1.htm IDEA: XBRL DOCUMENT v3.22.2
Cover
Jul. 28, 2022
Document Type 8-K
Amendment Flag false
Document Period End Date Jul. 28, 2022
Entity File Number 001-40001
Entity Registrant Name COMPUTE HEALTH ACQUISITION CORP.
Entity Central Index Key 0001828608
Entity Tax Identification Number 85-3449307
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 1105 North Market Street
Entity Address, Address Line Two 4th Floor
Entity Address, City or Town Wilmington
Entity Address, State or Province DE
Entity Address, Postal Zip Code 19890
City Area Code (212)
Local Phone Number 829-3500
Written Communications true
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant  
Title of 12(b) Security Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant
Trading Symbol CPUH.U
Security Exchange Name NYSE
Class A common stock, par value $0.0001 per share  
Title of 12(b) Security Class A common stock, par value $0.0001 per share
Trading Symbol CPUH
Security Exchange Name NYSE
Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50  
Title of 12(b) Security Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
Trading Symbol CPUH WS
Security Exchange Name NYSE
XML 8 ea163491-8k_compute_htm.xml IDEA: XBRL DOCUMENT 0001828608 2022-07-28 2022-07-28 0001828608 CPUH:UnitsEachConsistingOfOneShareOfClassaCommonStockAndOnequarterOfOneRedeemableWarrantMember 2022-07-28 2022-07-28 0001828608 CPUH:ClassaCommonStockParValue0.0001PerShareMember 2022-07-28 2022-07-28 0001828608 CPUH:RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassaCommonStockAtExercisePriceOf11.50Member 2022-07-28 2022-07-28 iso4217:USD shares iso4217:USD shares 0001828608 false 8-K 2022-07-28 COMPUTE HEALTH ACQUISITION CORP. DE 001-40001 85-3449307 1105 North Market Street 4th Floor Wilmington DE 19890 (212) 829-3500 true false false false Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant CPUH.U NYSE Class A common stock, par value $0.0001 per share CPUH NYSE Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 CPUH WS NYSE true false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2 html 4 24 1 false 3 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://computehealthacquisition.com/role/Cover Cover Cover 1 false false All Reports Book All Reports ea163491-8k_compute.htm cpuh-20220728.xsd cpuh-20220728_def.xml cpuh-20220728_lab.xml cpuh-20220728_pre.xml ea163491ex10-1_computehealth.htm http://xbrl.sec.gov/dei/2022 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "ea163491-8k_compute.htm": { "axisCustom": 0, "axisStandard": 1, "contextCount": 4, "dts": { "definitionLink": { "local": [ "cpuh-20220728_def.xml" ] }, "inline": { "local": [ "ea163491-8k_compute.htm" ] }, "labelLink": { "local": [ "cpuh-20220728_lab.xml" ] }, "presentationLink": { "local": [ "cpuh-20220728_pre.xml" ] }, "schema": { "local": [ "cpuh-20220728.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 66, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 24, "memberCustom": 3, "memberStandard": 0, "nsprefix": "CPUH", "nsuri": "http://computehealthacquisition.com/20220728", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "ea163491-8k_compute.htm", "contextRef": "From2022-07-28to2022-07-28", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://computehealthacquisition.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "ea163491-8k_compute.htm", "contextRef": "From2022-07-28to2022-07-28", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 3, "tag": { "CPUH_ClassaCommonStockParValue0.0001PerShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class\u00a0A common stock, par value $0.0001 per share" } } }, "localname": "ClassaCommonStockParValue0.0001PerShareMember", "nsuri": "http://computehealthacquisition.com/20220728", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "domainItemType" }, "CPUH_RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassaCommonStockAtExercisePriceOf11.50Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Redeemable warrants, each whole warrant exercisable for one share of Class\u00a0A common stock at an exercise price of $11.50" } } }, "localname": "RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassaCommonStockAtExercisePriceOf11.50Member", "nsuri": "http://computehealthacquisition.com/20220728", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "domainItemType" }, "CPUH_UnitsEachConsistingOfOneShareOfClassaCommonStockAndOnequarterOfOneRedeemableWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Units, each consisting of one share of Class\u00a0A common stock and one-quarter of one redeemable warrant" } } }, "localname": "UnitsEachConsistingOfOneShareOfClassaCommonStockAndOnequarterOfOneRedeemableWarrantMember", "nsuri": "http://computehealthacquisition.com/20220728", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "booleanItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://computehealthacquisition.com/role/Cover" ], "xbrltype": "stringItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r10": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r11": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r12": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r13": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r14": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r15": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r18": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r19": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r9": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" } }, "version": "2.1" } ZIP 15 0001213900-22-042964-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-22-042964-xbrl.zip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�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end